Giulio Cossu

Q: What Schools Are Affiliated With Giulio Cossu

Giulio Cossu is affiliated with the following schools: University of Milan, University College London, Edith Cowan University, University of Pavia, University of Hamburg, Osaka University, Sapienza University of Rome, University of Manchester

Giulio Cossu's AcademicInfluence.com Rankings

Giulio Cossu

Biology

#10216

World Rank

#13523

Historical Rank

Cell Biology

#474

World Rank

#486

Historical Rank

biology Degrees

Download Badge

Biology

Giulio Cossu's Degrees

PhD Biology University of Milan

Why Is Giulio Cossu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giulio Cossu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Muscle regeneration by bone marrow-derived myogenic progenitors. (1998) (2849)
Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart (2004) (1518)
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells (2007) (979)
Redefining the Genetic Hierarchies Controlling Skeletal Myogenesis: Pax-3 and Myf-5 Act Upstream of MyoD (1997) (854)
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs (2006) (760)
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts (2003) (645)
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. (2010) (611)
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. (2007) (579)
The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. (2002) (521)
Skeletal myogenic potential of human and mouse neural stem cells (2000) (504)
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation (2004) (477)
In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. (1999) (448)
Skeletal Myogenic Progenitors Originating from Embryonic Dorsal Aorta Coexpress Endothelial and Myogenic Markers and Contribute to Postnatal Muscle Growth and Regeneration (1999) (440)
Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. (2011) (425)
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration (2001) (399)
Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. (2005) (385)
Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. (2004) (384)
Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. (1998) (379)
Collagen VI regulates satellite cell self-renewal and muscle regeneration (2013) (378)
Transplantation of Genetically Corrected Human iPSC-Derived Progenitors in Mice with Limb-Girdle Muscular Dystrophy (2012) (339)
Wnt signaling and the activation of myogenesis in mammals (1999) (330)
No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels (2016) (328)
Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. (2012) (283)
The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development (1991) (281)
Cellular heterogeneity during vertebrate skeletal muscle development. (2007) (266)
Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues. (2003) (261)
Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice (1995) (256)
Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation (2007) (254)
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. (2004) (250)
How is myogenesis initiated in the embryo? (1996) (244)
Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. (1996) (238)
Autologous Transplantation of Muscle-Derived CD133+ Stem Cells in Duchenne Muscle Patients (2007) (233)
New ISSCR guidelines underscore major principles for responsible translational stem cell research. (2008) (230)
Inflammatory and alternatively activated human macrophages attract vessel‐associated stem cells, relying on separate HMGB1‐ and MMP‐9‐dependent pathways (2009) (227)
Pericyte–fibroblast transition promotes tumor growth and metastasis (2016) (205)
The Wnt/β-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis (2006) (194)
Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo (2018) (184)
New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. (2007) (175)
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle (2010) (171)
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy (2007) (168)
Lancet Commission: Stem cells and regenerative medicine (2017) (159)
Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome (2006) (159)
Differential response of embryonic and fetal myoblasts to TGF beta: a possible regulatory mechanism of skeletal muscle histogenesis. (1994) (151)
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? (2000) (151)
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability (2006) (149)
Stem Cell–Mediated Transfer of a Human Artificial Chromosome Ameliorates Muscular Dystrophy (2011) (146)
Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. (2005) (144)
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Δ48-50 DMD cells (2002) (142)
A population of myogenic cells derived from the mouse neural tube (1994) (137)
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. (1998) (134)
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells. (2007) (133)
Chapter 9 Cell Heterogeneity in The Myogenic Lineage (1987) (127)
PlGF–MMP-9–expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle (2008) (125)
Establishing myogenic identity during somitogenesis. (1997) (124)
Uno, nessuno e centomila: searching for the identity of mesodermal progenitors. (1999) (122)
Advances in stem cell research and therapeutic development (2019) (121)
‘Advanced’ generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo (2003) (121)
Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases (2002) (116)
Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. (2007) (112)
Myoblast differentiation during mammalian somitogenesis is dependent upon a community effect. (1995) (111)
The expression of slow myosin during mammalian somitogenesis and limb bud differentiation (1988) (109)
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle (2008) (108)
Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation (2010) (106)
A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. (2009) (103)
Differential activation of Myf 5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf 5 (1998) (102)
Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis (1999) (101)
In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. (1980) (99)
Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity. (2007) (99)
Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms: A Comparison With Bone Marrow Progenitors, Fibroblasts, and Endothelial Cells (2005) (96)
Differential response of satellite cells and embryonic myoblasts to a tumor promoter. (1983) (96)
Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. (2005) (93)
Msx2 and Necdin Combined Activities Are Required for Smooth Muscle Differentiation in Mesoangioblast Stem Cells (2004) (92)
Stem cell therapies for muscle disorders. (2012) (90)
Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. (2001) (90)
Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis (2008) (89)
Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy (2015) (88)
Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. (1999) (88)
Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. (2008) (88)
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle (2006) (85)
Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. (1998) (84)
Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion (2006) (82)
Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration (2012) (81)
TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts (2004) (80)
Mouse orthologue of ARX, a gene mutated in several X‐linked forms of mental retardation and epilepsy, is a marker of adult neural stem cells and forebrain GABAergic neurons (2004) (79)
Intrinsic cell memory reinforces myogenic commitment of pericyte‐derived iPSCs (2011) (79)
Sphingosine 1‐Phosphate Mediates Proliferation and Survival of Mesoangioblasts (2007) (78)
In vivo generation of a mature and functional artificial skeletal muscle (2015) (78)
Neural control of early myogenic differentiation in cultures of mouse somites. (1986) (77)
miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors (2011) (76)
The origin of embryonic and fetal myoblasts: a role of Pax3 and Pax7. (2009) (75)
PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence (2015) (72)
Cell heterogeneity in the myogenic lineage. (1987) (70)
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors (2018) (70)
Vitamin A inhibits chondrogenesis but not myogenesis. (1980) (69)
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle (2006) (68)
New therapies for muscular dystrophy: cautious optimism. (2004) (66)
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. (1993) (66)
Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy (2016) (66)
The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. (2009) (64)
Regulatory evaluation of Glybera in Europe — two committees, one mission (2013) (64)
Negative Regulation of β Enolase Gene Transcription in Embryonic Muscle Is Dependent upon a Zinc Finger Factor That Binds to the G-rich Box within the Muscle-specific Enhancer* (1998) (63)
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy (2006) (62)
Emergence of TPA-resistant 'satellite' cells during muscle histogenesis of human limb. (1985) (59)
Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation (2007) (58)
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy (2010) (58)
Nfix Regulates Temporal Progression of Muscle Regeneration through Modulation of Myostatin Expression (2016) (55)
Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures (2011) (55)
REN: a novel, developmentally regulated gene that promotes neural cell differentiation. (2002) (55)
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. (1995) (54)
Acetylcholine receptor channels are present in undifferentiated satellite cells but not in embryonic myoblasts in culture. (1987) (54)
'Early' mammalian myoblasts are resistant to phorbol ester-induced block of differentiation. (1988) (54)
Extracellular HMGB 1 , a signal of tissue damage , induces mesoangioblast migration and proliferation (2004) (52)
The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis. (1996) (50)
Neural Stem Cells: Plasticity and Their Transdifferentiation Potential (2002) (50)
Expression of protein kinase C genes during ontogenic development of the central nervous system (1989) (50)
Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memory. (2013) (50)
Transplanted Mesoangioblasts Require Macrophage IL-10 for Survival in a Mouse Model of Muscle Injury (2012) (50)
Lactosaminoglycans and heparan sulfate are covalently bound to fibronectins synthesized by mouse stem teratocarcinoma cells. (1983) (50)
Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. (2009) (49)
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. (1999) (48)
Paracrine stimulation of senescent satellite cell proliferation by factors released by muscle or myotubes from young mice (1993) (46)
Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles. (2020) (45)
Corrigendum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs (2013) (45)
Pericytes in Development and Pathology of Skeletal Muscle (2013) (44)
Distinct Cellular Mechanisms Underlie Smooth Muscle Turnover in Vascular Development and Repair (2017) (44)
Embryonic Stem–Derived Versus Somatic Neural Stem Cells: A Comparative Analysis of Their Developmental Potential and Molecular Phenotype (2006) (43)
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy (2016) (42)
Oriented Cell Divisions and Muscle Satellite Cell Heterogeneity (2007) (40)
Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle Biopsies (2007) (40)
Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin (2012) (40)
ADAMTS10-mediated tissue disruption in Weill–Marchesani syndrome (2018) (40)
Targeting endothelial junctional adhesion molecule-A/ EPAC/ Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles (2013) (39)
Adrenocorticotropin is a specific mitogen for mammalian myogenic cells. (1989) (39)
Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development. (1990) (39)
TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. (1993) (38)
Induced early expression of mrf4 but not myog rescues myogenesis in the myod/myf5 double-morphant zebrafish embryo (2009) (37)
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability (2006) (37)
Combined Notch and PDGF Signaling Enhances Migration and Expression of Stem Cell Markers while Inducing Perivascular Cell Features in Muscle Satellite Cells (2019) (36)
Globular Adiponectin as a Complete Mesoangioblast Regulator: Role in Proliferation, Survival, Motility, and Skeletal Muscle Differentiation (2010) (36)
Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy (2014) (35)
Skeletal Muscle Differentiation of Embryonic Mesoangioblasts Requires Pax3 Activity (2009) (35)
Sox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts (2010) (35)
The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis. (2013) (34)
Bsx, an evolutionary conserved Brain Specific homeoboX gene expressed in the septum, epiphysis, mammillary bodies and arcuate nucleus. (2004) (34)
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. (2009) (33)
A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle. (2008) (33)
Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. (2006) (32)
Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration (2012) (32)
Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. (2013) (32)
Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion (2013) (32)
TPA-induced inhibition of the expression of differentiative traits in cultured myotubes: dependence on protein synthesis. (1982) (31)
Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation. (1982) (31)
Determination, diversification and multipotency of mammalian myogenic cells. (2000) (30)
Bioengineering a Human Face Graft: The Matrix of Identity (2017) (30)
Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo (2013) (29)
Transformation by Rous sarcoma virus induces similar patterns of glycosaminoglycan synthesis in chick embryo skin fibroblasts and vertebral chondroblasts. (1983) (29)
Absence of MEF2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle. (1997) (29)
Unorthodox myogenesis: possible developmental significance and implications for tissue histogenesis and regeneration. (1997) (29)
Bhlhb5 is expressed in the CNS and sensory organs during mouse embryonic development. (2003) (29)
The homeobox gene Arx is a novel positive regulator of embryonic myogenesis (2008) (28)
Nfix Induces a Switch in Sox6 Transcriptional Activity to Regulate MyHC-I Expression in Fetal Muscle (2016) (28)
The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo (2012) (27)
-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts (2011) (27)
Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo (2011) (27)
The Wnt/ (cid:2) -catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis (2006) (26)
Fusion of bone marrow-derived stem cells with striated muscle may not be sufficient to activate muscle genes. (2004) (25)
Ren (2002) (25)
c-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging (2010) (25)
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next‐generation human artificial chromosomes for Duchenne muscular dystrophy (2017) (25)
Myosin Light Chain 3 F Regulatory Sequences Confer Regionalized Cardiac and Skeletal Muscle Expression in Transgenic Mice (2002) (25)
Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients (2008) (24)
Differentiation-dependent expression of apolipoprotein A-I in chicken myogenic cells in culture. (1990) (24)
‘Hearts and bones’: the ups and downs of ‘plasticity’ in stem cell biology (2012) (24)
Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution (2013) (24)
Sphingosine 1-Phosphate Induces Differentiation of Mesoangioblasts towards Smooth Muscle. A Role for GATA6 (2011) (23)
Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming (2017) (22)
Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts’ Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model (2016) (22)
Skeletal myogenic progenitors in the endothelium of lung and yolk sac. (2003) (21)
Lactosaminoglycans synthesized by mouse male germ cells are fucosylated by an epididymal fucosyltransferase. (1984) (21)
Reduced acetylcholine sensitivity in dystrophic mouse myotubes in vitro (1984) (21)
Bisperoxovanadium, a phospho‐tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype (2007) (20)
Expression of adult fast pattern of acetylcholinesterase molecular forms by mouse satellite cells in culture. (1987) (20)
Mesoangioblasts from ventricular vessels can differentiate in vitro into cardiac myocytes with sinoatrial-like properties. (2010) (20)
Expression of the extracellular fatty acid binding protein (Ex-FABP) during muscle fiber formation in vivo and in vitro. (1998) (19)
Membrane acetylcholinesterase in murine muscular dystrophy In vivo and in cultured myotubes (1985) (19)
Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD. (2014) (19)
Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation (2011) (19)
Development of 'revertant' myotubes in cultures of Rous sarcoma virus transformed avian myogenic cells. (1983) (18)
Binding of sFRP-3 to EGF in the Extra-Cellular Space Affects Proliferation, Differentiation and Morphogenetic Events Regulated by the Two Molecules (2008) (18)
Challenges in translational research (2009) (18)
Vessel-Associated Multipotent Stem Cells , Repair the Infarcted Heart by Multiple Cellular Mechanisms A Comparison With Bone Marrow Progenitors , Fibroblasts , and Endothelial Cells (2005) (18)
Dmbx1 is a paired-box containing gene specifically expressed in the caudal most brain structures (2002) (17)
Clinical development of gene therapy needs a tailored approach: a regulatory perspective from the European Union. (2014) (17)
A role for MSX2 and necdin in smooth muscle differentiation of mesoangioblasts and other mesoderm progenitor cells. (2005) (17)
An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis (2011) (17)
Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts. (1982) (16)
Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform (2019) (16)
Stress response in mesoangioblast stem cells (2006) (16)
Cell therapy of primary myopathies. (2005) (15)
Noggin recruits mesoderm progenitors from the dorsal aorta to a skeletal myogenic fate (2012) (14)
Altered distribution of protein kinase C in dystrophic muscle cells and its modulation by liposome-delivered phospholipids. (1986) (14)
Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There? (2018) (13)
Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. (2019) (13)
Variation of the carbohydrates of glycoproteins of cells growing on different surfaces (1982) (13)
HDAC8 regulates canonical Wnt pathway to promote differentiation in skeletal muscles (2018) (13)
Differentiation dependent expression in muscle cells of ZT3, a novel zinc finger factor differentially expressed in embryonic and adult tissues (1996) (13)
Transgelin-expressing myofibroblasts orchestrate ventral midline closure through TGFβ signalling (2017) (13)
Fusion‐independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells (2004) (13)
Regenerative medicine: challenges and opportunities (2020) (13)
Appearance of a class of cell-surface fucosyl-glycopeptides in differentiated muscle cells in culture. (1980) (13)
Hsp70 is required for optimal cell proliferation in mouse A6 mesoangioblast stem cells. (2009) (12)
ACTH-like peptides in postimplantation mouse embryos: a possible role in myoblast proliferation and muscle histogenesis. (1992) (12)
Covalent binding of lactosaminoglycans and heparan sulphate to fibronectin synthesized by a human teratocarcinoma cell line. (1983) (12)
TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating the SMAD2/3 transcription factors (2019) (11)
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle (2021) (11)
Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways (2013) (11)
[Effect of Centella asiatica on the biosynthetic activity of fibroblasts in culture]. (1984) (11)
Increased endocytosis of acetylcholine receptors by dystrophic mouse myotubes in vitro. (1985) (11)
Non-viral induction of transient cell reprogramming in skeletal muscle to enhance tissue regeneration (2017) (10)
Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts. (2011) (10)
Myogenesis in the mouse embryo. (1997) (10)
Effect of phorbol esters and liposome-delivered phospholipids on the differentiation program of normal and dystrophic satellite cells. (1986) (9)
A muscle cell line from dystrophic mice expressing an altered phenotype in vitro. (1986) (9)
Properties of acetylcholine-receptor activation in human Duchenne muscular dystrophy myotubes (1989) (9)
Reduced acetylcholine-induced channel activity in dystrophic mouse myotubes (1988) (9)
Biosynthetic changes in myosin heavy subunit during myogenesis in culture. (1978) (9)
Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution (2013) (8)
Liposome-delivered phosphatidylcholine enhances the acetylcholine sensitivity of dystrophic mouse myotubes. (1986) (8)
Abrogation of TGF-beta signalling in TAGLN expressing cells recapitulates Pentalogy of Cantrell in the mouse (2018) (8)
Increased sialylation of complex glycopeptides during differentiation of mouse embryonal carcinoma cells. (1985) (8)
Pro‐opiomelanocortin gene is expressed in post‐implantation mouse embryos and enhances growth potential of myogenic cells (1993) (7)
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene tranfer (1998) (7)
Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells. (1992) (7)
Synthesis of glycoconjugates in mouse primordial germ cells. (1985) (7)
TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating SMAD2/3 transcription factors (2019) (6)
Non Muscle Stem Cells and Muscle Regeneration (2008) (6)
Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo (2020) (5)
A temperature-conditional mutant of simian virus 40 large T antigen requires serum to inhibit myogenesis and does not induce DNA synthesis in myotubes. (1997) (5)
MCAM contributes to the establishment of cell autonomous polarity in myogenic and chondrogenic differentiation (2017) (5)
Myogenic potential of mouse primordial germ cells. (2003) (5)
Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs (2012) (5)
THE BOUND CARBOHYDRATES OF GLYCOPROTEINS IN NORMAL AND PATHOLOGICAL STATES * (1982) (4)
Biosynthesis of dTTP during differentiation of chick embryo myoblasts in culture: changes in thymidine kinase, thymidilate kinase and thymidilate synthetase activities. (1979) (4)
Induction of dedifferentiation in cultured myotubes by TPA (1981) (3)
Alterations of lipid composition in a dystrophic muscle cell line. (1986) (3)
Erratum to "Satellite cells, myoblasts and other occasional myogenic progenitors: Possible origin, phenotypic features and role in muscle regeneration" by Giulio Cossu, Stefano Biressi (Semin. Cell Dev. Biol. 16 (4-5) (2005) 623-631) (2006) (3)
Developmental changes in glycopeptides synthesized by normal and dystrophic satellite cells in culture. (1981) (3)
Bystander Effect on Brain Tissue of Mesoangioblasts Producing Neurotrophins (2012) (3)
DNA replication during muscle cell differentiation: identification of multiple DNA-dependent DNA polymerases. (1977) (3)
Glycopeptide alterations induced by 12-O-tetradecanoyl phorbol-13-acetate in chick embryo cultured myotubes. (1982) (3)
Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state (2021) (3)
Altered Glycoprotein Carbohydrates in Malignant Cells (1983) (3)
Erratum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs (Nature (2013) 494 (506) DOI: 10.1038/nature11976)) (2014) (2)
Msx-2 and Necdin in mesoangioblast and smooth muscle differentiation. (2005) (2)
Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential (2021) (2)
Advances in stem cell research and therapeutic development (2019) (2)
D1.4 Oesophageal tissue engineering: preliminary evaluation of a 2 stage surgical approach in a mouse model (2017) (2)
MAR-Mediated Dystrophin Expression in Mesoangioblasts for Duchenne Muscular Dystrophy Cell Therapy (2015) (2)
Sampaolesi et al. reply (2007) (2)
Changes in protein and glycoprotein biosynthesis during differentiation of satellite cells in vitro. (1982) (2)
Autologous progenitor cells in a hydrogel form a supernumerary and functional skeletal muscle in vivo (2012) (2)
Challenges in cell transplantation for muscular dystrophy. (2021) (2)
Localization of beta-D-galactosidase activity in semithin epon sections of embryonic tissues using differential interference contrast optics. (1997) (2)
Functional interactions between mouse primordial germ cells and somatic cells in vitro (1987) (1)
Raw data for Figure 5: The presence of IDO and PGE-2 inhibitors reduce the suppression of T cell proliferation by Mesoangioblasts/HIDEMs (2013) (1)
Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State (2019) (1)
The Transcriptional Regulator Prdm1 Is Essential for the Early Development of the Sensory Whisker Follicle and Is Linked to the Beta-Catenin First Dermal Signal (2022) (1)
DEVELOPMENT OF A BIOARTIFICIAL OESOPHAGUS ENGINEERED WITH PRIMARY MESOANGIOBLASTS, NEURAL AND EPITHELIAL CELLS FOR PRECLINICAL STUDIES (2017) (1)
Disruptive influence (2013) (1)
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migratiobn ability (vol 174, pg 231, 2006) (2006) (1)
Challenges and potential in regenerative medicine: A joint report from EASAC and FEAM (2020) (1)
Expression of the extracellular fatty acid-binding protein during muscle fiber formationin Vivo andin Vitro (2007) (1)
Mesoangioblast-based supplementation of neurotrophic factors for the treatment of neuronal damage (2010) (1)
Chapter 6 Somitic and non somitic progenitors of skeletal muscle (2002) (1)
The mesoangioblast, a multipotent embryonic cell from dorsal aorta, repairs the infarcted heart: comparative efficacy with bone marrow-derived stem cells and fibroblasts (2004) (1)
Mesoangioblasts, vessel associated stem cells, repair skeletal muscle in animal models of muscular dystrophies (2005) (1)
Direct conversion of pericyte-derived cells of the adult human brain into functional neurons (2012) (1)
Out of the niche: exploring unknown pathways (2014) (1)
A discussion on cell therapy in Manchester. (2016) (1)
Cost and availability of novel cell and gene therapies (2023) (1)
Corrigendum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs (2014) (1)
Towards a Cell Therapy for Muscular Dystrophy: Technical and Ethical Issues (2011) (1)
Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands (2021) (1)
Brief Communication Arising in Replying to Bretag AH (2007) (1)
Gene and cell therapies for muscular dystrophies (2015) (1)
Altered protein phosphorylation in murine muscular dystrophy (1990) (1)
Tedesco Ameliorates Muscular Dystrophy Mediated Transfer of a Human Artificial Chromosome − Stem Cell (2011) (0)
Ex vivo gene therapy for myopathies: how to get enough myogenic cells? (1996) (0)
Abstract 1053: Identification Of A Novel Type Of Circulating Progenitor Cells Resembling Multipotent Mesoangioblasts From Peripheral Blood Of Children (2007) (0)
Subject Index Vol. 159, 1997 (1997) (0)
Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo (2018) (0)
BIOMETRA 2018 Organizing and Scientific Committee (2018) (0)
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY (2006) (0)
The discovery of a new role of HDAC8 in skeletal muscle differentiation and in centronuclear myopathy insurgence (2018) (0)
Inflammation converts immunologically inert human mesoangioblasts into sensitizers and targets of the alloreactive response: implications for allogeneic cell therapy of DMD (2011) (0)
Back from the Tip of the Nose (2001) (0)
P4.35 Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne muscular dystrophy (2010) (0)
Molecular biology and pathology of skeletal and cardiac myogenesis 25 September–1 October 1992 (1993) (0)
OP-1 ARTIFICIAL OESOPHAGUS ENGINEERING IN A 3D DYNAMIC CULTURE. (2015) (0)
Abstract 3958: Hepatocyte Growth Factor Mobilises Multipotent Mesoangioblasts (2008) (0)
Problems and Hopes with Cell Therapy: The Case of Muscular Dystrophy (2005) (0)
There is increasing evidence for a positive role of Wnt signaling molecules in the activation of myogenesis in amniote (1999) (0)
O.29Engineering stem cell fate determinants for myogenic cell therapies: Notch and PDGF signalling promote stemness and migration of muscle satellite cells and human iPS cell derived myogenic progenitors (2019) (0)
Muscle determination in zebrafish (2008) (0)
Skeletal muscle tissue engineering: a challenge for novel dynamic bioreactors (2004) (0)
T.P.6.01 Possible role of RTX in the differentiation of pericyte-like cells in Duchenne muscular dystrophy (2009) (0)
Bioengineering a Human Face Graft of Identity The Matrix (2017) (0)
G.P.13.14 Ex vivo treatment with TSA and IGF-1 induces myogenic differentiation of inclusion-body myositis mesoangioblasts (2007) (0)
Analysis and in vivo characterization of the minimal enhancer region of ARX, a gene specifically expressed in the developing forebrain (2004) (0)
Correction 174, p. 231 (2006) (0)
Human artificial chromosome-mediated genetic correction of human dystrophic skeletal muscle progenitors for the autologous cell therapy of Duchenne muscular dystrophy (2015) (0)
Molecular characterization of adult cardiac stem cells during differentiation towards a pacemaker phenotype (2006) (0)
Human artificial chromosome-mediated strategies for stem cell-based therapy of muscular dystrophy (2015) (0)
T.I.2 Toward the cell therapy for muscular dystrophies (2007) (0)
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors (2018) (0)
Differentiation-dependent expression of APO A-I in myogenic cells (1990) (0)
Procede d'induction de la differentiation des cellules endotheliales dans des cardiomyocites (2002) (0)
Expression of the inducible nitric oxide synthase gene in (2015) (0)
O15. Nitric oxide, mitochondria and their dynamics in myogenesis (2008) (0)
Erratum to: Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs (2012) (0)
Ontogeny of Skeletal Muscle Cells (2002) (0)
O03 Cell therapy for muscular dystrophies (2014) (0)
Marfan syndrome and mitral valve prolapse (2004) (0)
Bellugi, Ursula, 139 Berent, Iris, 203 (1993) (0)
Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs (2012) (0)
Differential expression of MSE in embryonic and fetal myogenic cells (1990) (0)
The mouse orthologue of ARX, a gene mutated in several X-linked forms of mental retardation and epilepsy, is an early marker of most forebrain GABAergic neurons (2004) (0)
G.P.16.06 Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy (2007) (0)
Erratum to: Isolation, Characterization and Differentiation Potential of Cardiac Progenitor Cells in Adult Pigs (2012) (0)
19-P004 Endothelial derived myogenesis: Lineage tracing and contribution to muscle regeneration (2009) (0)
protein for extracellular matrix components immobilization reveals alterations in mRNA and Analysis of human skeletal muscle after 48 h (2015) (0)
P66 iPS cells and human artificial chromosomes: novel therapeutic tools for muscle disorders (2014) (0)
Evolutionary role of the skeletal muscle in vertebrates: NfIx role during muscle development in mammals and zebrafish (Danio rerio) (2010) (0)
Skeletal muscle differentiation on a chip shows human donor mesoangioblasts efficiency in restoring dystrophin in a DMD model (2016) (0)
Abstract 855: Circulating Mesoangioblasts Differentiate Into Cardiac Myocytes And Improve Function After Acute Myocardial Infarction (2007) (0)
Abstract 3487: Sox2 Transduction Induces Pluripotency and Enhances Cardiovascular Repair Capacity of Blood-derived Mesoangioblasts (2009) (0)
Novel treatments under development for muscular dystrophy. (2004) (0)
Regulation of Spermatogenesis in Mammals: Intragonadal Mechanisms. (1984) (0)
de Lázaro, I and Yilmazer, A and Nam, Y and Qubisi, S and Razak, FMA and Degens, H and Cossu, G and Kostarelos, K (2018)Non-viral, Tumor- free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue (2020) (0)
Contents, Vol. 159, 1997 (1997) (0)
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis (2019) (0)
Differentiation in Culture of Myogenic Cells from Adult Mouse Muscle (1978) (0)
ON STEM CELLS FOR LIGAMENT AND TENDON TISSUE ENGINEERING AND REGENERATION (2014) (0)
S5/2 Regulation of mitochondrial dynamics by nitric oxide is a key event in myogenesis (2008) (0)
muscular dystrophy The role of free radicals in the pathophysiology of (2015) (0)
Reconstruction of Gut Muscle Layer: Mesoangioblasts' Delivery Optimization in Decellularised Scaffolds (2015) (0)
Molecular biology and pathology of skeletal and cardiac myogenesis. EMBO Workshop, Baia di Conti, Sardinia, 25 September-1 October 1992. (1993) (0)
MyoD, MyogeninIndependentDifferentiation ofPrimordialMyoblastsinMouse Somites (1992) (0)
Human mesoangioblasts can elicit alloreactive T-cell immune responses: implications for allogeneic cell therapy of DMD (2012) (0)
From developmental biology to dysmorphology (2000) (0)
Changes of Protein Glycosylation During Differentiation of Mouse Embryonal Carcinoma Cells (1983) (0)
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy (2010) (0)
T.P.1 08 Autologous transplantation of muscle-derived AC133+ stem cells (2006) (0)
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle (2008) (0)
Magic F1, a dimerized c-met binding domain, induces muscle hypertrophy by protecting from apoptosis myogenic progenitors (2006) (0)
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy (2008) (0)
Short-term treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy (2006) (0)
Raw data for Figure 4A: Neutralising antibodies against IFN-γ and TNF-α reduce the immunosuppressive capacity of Mesoangioblasts/HIDEMs (2013) (0)
65 – Stem Cells for the Treatment of Muscular Dystrophy: More Than Wishful Thinking? (2004) (0)
Development of an Artificial Oesophagus Engineered with Mesoangioblasts in a Peristaltic 3d Dynamic Culture (2015) (0)
Mesoangioblasts at 20: From the embryonic aorta to the patient bed (2023) (0)
Correction: Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration abilit (2006) (0)
The contracture-in-a-well. An in vitro model distinguishes bulk and interfacial processes of irreversible (fibrotic) cell-mediated contraction. (2022) (0)
Stem Cells for the Treatment of Muscular Dystrophy: Therapeutic Perspectives (2009) (0)
Stem Cells for the Treatment of Muscular Dystrophy (2013) (0)
Clinical development of Gene therapy needs a tailored approach: A regulatory perspective from the EU. (2014) (0)
MYOGENIC DETERMINATION IN MAMMALS (1996) (0)
Region- and time-specific expression of protein kinase C genes in post-natal development of central nervous system (1990) (0)
Electrospun polyesterurethane membranes provide a substrate for skeletal muscle cell differentiation (2005) (0)
Cachexia, a condition that kills about one-fifth of cancer patients, may be linked to Rb—a protein that is already linked to various cancers— moving from the cell nucleus to the cytoplasm. (2013) (0)
T.P.6.03 Restoring cell-basal lamina interaction to rescue tissue degeneration in congenital muscular dystrophy (2009) (0)
Directing human and murine myogenic cell differentiation on a novel microfibrous polymeric scaffold (2005) (0)
Abrogation of TGF-beta signalling in TAGLN expressing cells recapitulates Pentalogy of Cantrell in the mouse (2018) (0)
From zebrafish (Danio rerio) to mouse, the function of Nfix in skeletal muscle development is partially conserved during the evolution (2011) (0)
Model of Muscle Injury Macrophage IL-10 for Survival in a Mouse Transplanted Mesoangioblasts Require (2012) (0)
Reporter-Based Isolation of Developmental Myogenic Progenitors (2018) (0)
Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration (2012) (0)
Cell therapy of the golden retriever muscular dystrophy by systemic delivery of donor mesoangioblasts (2006) (0)
Chapter 36 – Stem Cells for the Treatment of Muscular Dystrophy (2014) (0)
Artificial Oesophagus Engineering in a 3D Dynamic Culture (vol 61, pg 509, 2015) (2016) (0)
Myogenic potential of human circulating AC133+ stem cells in murine dystrophic skeletal muscle (2005) (0)
Cell biology international reports, vol. 5, no. 6, June 1981. (1981) (0)
Cardiac-derived mesoangioblasts can differentiate into autorhythmic myocytes (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giulio Cossu?

Giulio Cossu is affiliated with the following schools: